The total return over the past 12 months is +172.53% vs. +16.94% for the S&P 500. So far it's up +115.36% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +125.64% | +57.62% | +20.95% | +3.53% | +1.51% | N/A |
| Total Return CAGR | +172.53% | +67.91% | +25.62% | +5.52% | +2.81% | N/A |
| Revenue CAGR | (25.68%) | (8.37%) | +3.53% | +0.06% | (3.09%) | +7.39% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (115.92%) | N/A | N/A | N/A | N/A | +4.26% |
| Operating Cash Flow CAGR | (89.53%) | (58.02%) | (34.52%) | (5.15%) | (11.33%) | +3.63% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cumberland Pharmaceuticals Inc. (CPIX)
| Year | Start price | End price | CPIX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.98 | $7.09 | +115.36% | +14.51% | +100.85% |
| 2025 | $2.37 | $3.98 | +67.93% | +17.72% | +50.21% |
| 2024 | $1.79 | $2.37 | +32.40% | +24.89% | +7.51% |
| 2023 | $2.25 | $1.79 | (20.44%) | +26.19% | (46.63%) |
| 2022 | $4.67 | $2.25 | (51.82%) | (18.17%) | (33.65%) |
| 2021 | $2.95 | $4.67 | +58.31% | +28.74% | +29.57% |
| 2020 | $5.15 | $2.95 | (42.72%) | +18.37% | (61.09%) |
| 2019 | $6.03 | $5.15 | (14.59%) | +31.22% | (45.81%) |
| 2018 | $7.36 | $6.03 | (18.07%) | (4.56%) | (13.51%) |
| 2017 | $5.50 | $7.36 | +33.82% | +21.70% | +12.12% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
